The Sage Group
About
Services
Sage China
Sage Japan
Sage India
Team
Clients
News
Downloads
Contact
More
Sage Group Represents Solvotrin to License Their Novel ActiveIronTM Product Portfolio
Sage Represents Mateon Therapeutics - Leadership in Novel Vascular Targeted Therapy
BullFrog AI Partners with the Sage Group to Explore JV Opportunities to Advance its Oncology Assets
The Sage Group advised Zhimeng Biopharma on a worldwide license to GSK of CB06-036, a TLR8 Agonist
AeroNeph Therapeutics Announces Search for Strategic Partners for Novel Drugs for Renal Disease
Eurofins Discovery Announces Aquisition of Sage Client Discovery BioMed
Kinnov Therapeutics Completes Successful Phase 2 study for Alcohol Use Disorder
Hatchtech appoints Sage Group to divest its FDA-approved Xeglyze® for head lice treatment
Sage Advises Cancer Prevention Pharmaceuticals on Merger with Panbela Therapeutics
Product Opportunity for Rare Hematological Disease - KDFX for Iron Overload Disorder from Dispersol
Opportunity in Cellular Immunotherapy with oNKord Unmodified Natural Killer Cells from Glycostem
SalivaPod - Novel Saliva Sample Collection for a New Era of Diagnostics
